🌍·1d agodiscovery
Australian company announces agreement with Lilly to trial lung cancer combination
Publisher
P
PharmaDispatch
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- PharmaDispatch
- Region
- Global
- Scope
- discovery
- Published
- August 4, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: PharmaDispatch
Scope: discovery
Related coverage
More related coverage
Pharmaceutical Executive/3h ago
Mergers as Strategic Architecture: Rethinking How to Evaluate the AstraZeneca–BMS Rumors
fiercebiotech.com/3h ago
Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027
koreabiomed.com/4h ago
Onconic’s GERD drug Jaqbo wins first overseas approval in India
pharmaphorum/4h ago